RVTY

#713
Revvity, Inc.
98.3650
+2.62%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
97.7300
98.3800
Intervallo Annuale
88.4750
118.2600
Variazione giornaliera
+2.62%
Variazione Mensile
-13.97%
Variazione di 6 mesi
+3.69%
Variazione Annuale
+3.69%
Chiusura Precedente
95.8500
Open
97.7300
Bid
Ask
Low
97.7300
High
98.3800
Volume
436
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization 11.4637 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
46.91
Price to sales ratio
3.96
Dividends per share
0.28
Dividend yield %
0.29

Revvity Inc

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

Notizie